Karl Deisseroth

Over the past seven years, an in situ chemical synthesis approach to biological systems has emerged in which functional materials are assembled within tissues such as the brain — either constructed throughout the intact tissue (hydrogel-tissue chemistry/HTC), or genetically targeted to certain cell types (genetically-targeted chemical assembly/GTCA). Resulting hybrid materials are endowed with diverse capabilities, including the anchoring and labeling of RNA and proteins, in situ sequencing, transparency, reversible size changes, and electrical insulation or conduction. Dr. Deisseroth will discuss the principles and practice of this new way of interacting with biological systems.

Is this you? Claim this profile →